GlassScriptPhysician profile
Mithun K Neral
NPI 1699195990
$4,875.23
in general payments reported to CMS, 2019-2025
20 companies · $378 in 2025
The $378 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $37.80 · 2021: $42.48 · 2022: $238 · 2023: $2,728 · 2024: $1,452 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,420 · Food and Beverage: $2,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,419.79 |
| Food and Beverage | $2,137.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $1,915.16 | 2023-2024 | |
| Stryker Corporation | $1,357.06 | 2022-2025 | Na, T2, Gamma |
| Arthrex, INC. | $750.54 | 2023-2024 | Shoulder Implants Fibertak Knotless |
| Smith+Nephew, INC. | $222.72 | 2020-2025 | Real Intelligence, K-15 Pork, Acufex |
| Bioventus LLC | $146.74 | 2021-2025 | Exogen Ultrasound Bone Healing System, Xcell, Durolane |
| Depuy Synthes Sales INC. | $115.96 | 2022-2024 | Dynacord, Orthovisc, Monovisc |
| Biotissue Holdings INC. | $61.28 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $34.97 | 2025 | Dupixent |
| Nevro Corp. | $33.72 | 2023 | Senza |
| Merz Pharmaceuticals, LLC | $32.10 | 2024 | Xeomin |
| Surgenex LLC | $31.60 | 2025 | Ardeograft, Surgraft, Pellograft |
| Convatec INC. | $28.02 | 2023 | |
| Sonex Health, INC. | $24.32 | 2025 | Sx-One Microknife |
| Vertex Pharmaceuticals Incorporated | $20.79 | 2025 | |
| Zimmer Biomet Holdings, INC. | $20.59 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $20.39 | 2023 | Exparel, Zilretta, Iovera |
| Treace Medical Concepts, INC. | $18.06 | 2024 | |
| Heron Therapeutics, INC. | $14.24 | 2023 | Zynrelef |
| Orthofix Medical, INC. | $13.94 | 2023 | Physio-Stim |
| Ferring Pharmaceuticals INC. | $13.03 | 2023 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mithun Neral listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.